SHANGHAI ALLIST PHARMACEUTICAL AND MEDICAL TECHNOLOGY CORPORATIONS
发明人:
KUANG, RONGREN
申请号：
CA3026592
公开号：
CA3026592A1
申请日:
2017.06.01
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to a fused pyrimidinopiperidine derivative as represented by formula (I), and a pharmaceutically acceptable salt and manufacturing method thereof, wherein R1, R2, R3, R4, R5, X, Y, and Z are defined in the specification. Further provided is an application of the fused pyrimidinopiperidine for manufacturing a pharmaceutical product for preventing or treating an FGFR kinase-induced disease such as cancer.
